Publications

Publications of specific relevance to Predictive in vitro Models
2020
Norling LV and
Perretti M (2020).
Proresolving lipid mediators enhance PMN-mediated bacterial clearance. Proceedings of The National Academy of Sciences of The United States of America vol. 117, (17) 9148-9150.
10.1073/pnas.2004241117
Norling L, Cooper D,
Law H, Wright R and Iqbal A (2020).
A pro-resolving role for Galectin-1 in acute inflammation. Frontiers Media Frontiers in Pharmacology vol. 11, (274)
10.3389/fphar.2020.00274
Topping LM, Thomas BL, Rhys HI, Tremoleda JL, Foster M, Seed M, Voisin MB, Vinci C,
Law HL,
Perretti M,
Norling LV,
Azevedo HS and Nissim A (2020).
Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific Antibody. Frontiers Media Frontiers in Immunology vol. 11,
10.3389/fimmu.2020.00010
Padovan MG and
Norling LV (2020).
Pro-resolving lipid mediators in sepsis and critical illness. Ovid Technologies (Wolters Kluwer Health) Current Opinion in Clinical Nutrition and Metabolic Care 1-1.
10.1097/mco.00000000000006332019
Oggero S, Austin-Williams S and
Norling LV (2019).
The contrasting role of extracellular vesicles in vascular inflammation and tissue repair. Frontiers Media Frontiers in Pharmacology vol. 10,
10.3389/fphar.2019.014792018

Rhys HI, Dell'Accio F#21631#, Pitzalis C#20329#, Moore A, Norling LV#24524# and Perretti M#20287# (2018).
Neutrophil Microvesicles from Healthy Control and Rheumatoid Arthritis Patients Prevent the Inflammatory Activation of Macrophages. Ebiomedicine vol. 29, 60-69.
10.1016/j.ebiom.2018.02.0032017

Piovezan AP, Batisti AP, Benevides MLACS, Turnes BL, Martins DF, Kanis L, Duarte ECW, Cavalheiro AJ, Bueno PCP, Seed MP,
Norling LV, Cooper D, Headland S, Souza PRPS and
Perretti M (2017).
Hydroalcoholic crude extract of Casearia sylvestris Sw. reduces chronic post-ischemic pain by activation of pro-resolving pathways. Journal of Ethnopharmacology vol. 204, 179-188.
10.1016/j.jep.2017.03.059
Norling LV, Ly L and Dalli J (2017).
Resolving inflammation by using nutrition therapy: roles for specialized proresolving mediators. Curr Opin Clin Nutr Metab Care vol. 20, (2) 145-152.
10.1097/MCO.0000000000000353
Ross EA, Naylor AJ, O'Neil JD, Crowley T, Ridley ML, Crowe J, Smallie T, Tang TJ, Turner JD, Norling LV#24524#, Dominguez S, Perlman H, Verrills NM, Kollias G, Vitek MP, Filer A, Buckley CD, Dean JL and Clark AR (2017).
Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression. Annals of The Rheumatic Diseases vol. 76, (3) 612-619.
10.1136/annrheumdis-2016-209424
Souza PR, Jones HR and
Norling LV (2017).
Novel immunoregulatory mediators produced from omega-3 fatty acids. Nutrition, Immunity, and Infection 10.1201/97813151189012016

Wright RD, Souza PR, Flak MB, Thedchanamoorthy P,
Norling LV and Cooper D (2016).
Galectin-3-null mice display defective neutrophil clearance during acute inflammation., Editors: Montaner LJ.
The Society For Leukocyte Biology J Leukoc Biol 10.1189/jlb.3A0116-026RR
Arnardottir HH, Dalli J,
Norling LV, Colas RA,
Perretti M and Serhan CN (2016).
Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation. American Association of Immunologists Journal of Immunology vol. 197, (6) 2362-2368.
10.4049/jimmunol.1502268
Souza PR and
Norling LV (2016).
Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis. European Journal of Pharmacology vol. 785, 165-173.
10.1016/j.ejphar.2015.05.072
Norling LV, Headland SE, Dalli J, Arnardottir HH, Haworth O, Jones HR, Irimia D, Serhan CN and
Perretti M (2016).
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. Jci Insight vol. 1, (5)
10.1172/jci.insight.859222015

Headland SE, Jones HR#35935#, Norling LV#24524#, Kim A, Souza PR, Corsiero E#28576#, Gil CD, Nerviani A#33687#, Dell'accio F#21631#, Pitzalis C#20329#, Oliani SM, Jan LY and Perretti M#20287# (2015).
Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Science Translational Medicine vol. 7, (315)
10.1126/scitranslmed.aac5608
Canova DF, Pavlov AM,
Norling LV, Gobbetti T, Brunelleschi S, Le Fauder P, Cenac N, Sukhorukov GB and
Perretti M (2015).
Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response. Journal of Controlled Release vol. 217, 284-292.
10.1016/j.jconrel.2015.09.021
Headland S,
Norling L, Kim A, Jones H, Jan L and Perretti M (2015).
Neutrophil-Derived Microvesicles Migrate into Cell-Impenetrable Cartilage to Protect the Joint During Inflammatory Arthritis. Faseb Journal vol. 29,
2014

Burgmaier M, Schutters K, Willems B, Van der Vorst EPC, Kusters D, Chatrou M,
Norling L, Biessen EAL, Cleutjens J,
Perretti M, Schurgers LJ and Reutelingsperger CPM (2014).
AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(-/-) mice. Journal of Cellular and Molecular Medicine vol. 18, (10) 2117-2124.
10.1111/jcmm.12374
Montero-Melendez T, Madeira MFM,
Norling LV, Alsam A, Curtis MA, da Silva TA and
Perretti M (2014).
Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3. Am J Pathol vol. 184, (8) 2333-2341.
10.1016/j.ajpath.2014.04.009
Headland SE, Jones HR#35935#, D'Sa ASV, Perretti M#20287# and Norling LV#24524# (2014).
Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep vol. 4,
10.1038/srep05237
Dalli J,
Norling LV, Montero-Melendez T, Federici Canova D, Lashin H, Pavlov AM, Sukhorukov GB, Hinds CJ and
Perretti M (2014).
Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis. Embo Mol Med vol. 6, (1) 27-42.
10.1002/emmm.2013035032013

Dalli J, Montero-Melendez T,
Norling LV, Yin X, Hinds C, Haskard D, Mayr M and
Perretti M (2013).
Heterogeneity in neutrophil microparticles reveals distinct proteome and functional properties. Mol Cell Proteomics vol. 12, (8) 2205-2219.
10.1074/mcp.M113.0285892012

Gil-Villa AM,
Norling LV, Serhan CN, Cordero D, Rojas M and Cadavid A (2012).
Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma. Prostaglandins Leukot Essent Fatty Acids vol. 87, (4-5) 127-134.
10.1016/j.plefa.2012.08.003
Norling LV, Dalli J, Flower RJ, Serhan CN and
Perretti M (2012).
Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol vol. 32, (8) 1970-1978.
10.1161/ATVBAHA.112.2495082011
Norling LV, Spite M, Yang R, Flower RJ,
Perretti M and Serhan CN (2011).
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. Journal of Immunology vol. 186, (10) 5543-5547.
10.4049/jimmunol.1003865
Norling LV, Spite M, Yang R, Flower RJ,
Perretti M and Serhan CN (2011).
Cutting Edge: Humanized Nano-Proresolving Medicines Mimic Inflammation-Resolution and Enhance Wound Healing. J Immunol vol. 186, (10) 5543-5547.
10.4049/jimmunol.10038652010

Canaider S, Vettraino M,
Norling LV, Spisni E, Facchin F, Cooper D and
Perretti M (2010).
Human RCAN3 gene expression and cell growth in endothelial cells. Int J Mol Med vol. 26, (6) 913-918.
10.3892/ijmm_00000542
Canaider S, Vettraino M,
Norling LV, Spisni E, Facchin F, Cooper D and
Perretti M (2010).
Human RCAN3 gene expression and cell growth in endothelial cells. Int J Mol Med vol. 26, (6) 913-918.
10.3892/ijmm_00000542
Norling LV and Serhan CN (2010).
Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med vol. 268, (1) 15-24.
10.1111/j.1365-2796.2010.02235.x
Norling LV, Dalli J, Flower RJ, Serhan CN and Perretti M (2010).
Resolvin D1 limits PMN recruitment to inflammatory loci: receptor dependent bioactions. Faseb Journal vol. 24,
2009

Spite M,
Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ,
Perretti M and Serhan CN (2009).
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature vol. 461, (7268) 1287-U125.
10.1038/nature08541
Piqueras L, Sanz MJ,
Perretti M, Morcillo E,
Norling L, Mitchell JA, Li Y and Bishop-Bailey D (2009).
Activation of PPAR beta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. J Leukocyte Biol vol. 86, (1) 115-122.
10.1189/JLB.05082842008

Cooper D,
Norling LV and
Perretti M (2008).
Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow. J Leukocyte Biol vol. 83, (6) 1459-1466.
10.1189/jlb.12078312007

Harrington LS, Evans RJ, Wray J,
Norling L, Swales KE, Vial C, Ali F, Carrier MJ and Mitchell JA (2007).
Purinergic 2X(1) receptors mediate endothelial dependent vasodilation to ATP. Mol Pharmacol vol. 72, (5) 1132-1136.
10.1124/mol.107.037325